Brief: Galmed Announces A Delay In The Initiation Of Its Primary Sclerosing Cholangitis (Psc) Phase 2A Study

Eocene

20/11/2023 21:48

Nov 20 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED ANNOUNCES A DELAY IN THE INITIATION OF ITS PRIMARY
SCLEROSING CHOLANGITIS (PSC) PHASE 2A STUDY
    * GALMED PHARMACEUTICALS LTD- NO LONGER WILL BE ABLE TO MEET
ORIGINAL PLANNED TIMELINES OF ITS PH1 STUDY
    * GALMED PHARMACEUTICALS LTD- CURRENTLY ESTIMATES A DELAY OF
6-9
MONTHS IN INITIATION OF PH2A PSC STUDY.
    * GALMED PHARMACEUTICALS LTD: "ATTACK OF HAMAS" ON OCTOBER 7
RESULTED IN A DISRUPTION OF OUR WORK

Source text for Eikon:  ID:nPnbcbYgYa 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))